Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Part of paid clinical trials in Chinle, Arizona.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT03326206
- Status
- Completed
Conditions
- Chronic Disease
- Diabetes Mellitus
- Hypertension
- Metabolic Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Since 2009, a programmatic community-based strategy (COPE) has been implemented to address health disparities among Navajo individuals living with multiple chronic conditions. COPE (Community Outreach and Patient Empowerment) targets individual, family, and health system-level factors through four activities: 1) coordination between community health representatives (CHRs) and Indian Health Service providers; 2) CHR competency with standardized training; 3) a culturally-sensitive health promotion curriculum for patients and families; and 4) strong CHR supervision. COPE has been implemented throughout Navajo Nation. Enrollment is programmatic; in other words, the decision to enroll a patient in COPE occurs independently of whether the patient is in this study. Participants receive the COPE intervention in the same manner and intensity, whether they are included in this observational study or not. The main goal of this observational research is to understand if COPE improves the lives of participating community members. The Primary Aim is to assess the impact of the COPE Project on changes in HbA1c and other CVD risk factors. Hypothesis: Patients enrolled in the COPE program will experience a reduction in HbA1c compared to the control group. Secondary aims are: 1) To understand if COPE improves patients' own self-reported outcomes. Hypothesis: COPE patients will report better health compared with their own baseline at 12 months. 2) To Identify factors associated with increased effectiveness of the COPE Project at the individual, community, and health system level using a mixed-model approach. 3) To understand diverse stakeholder perspectives on COPE impact and value among CHRs, providers and the health care system. Hypothesis: Compared with baseline, CHRs will report greater empowerment in their work, providers will report greater confidence in CHRs. The observational cohort will be comprised of individuals with diabetes receiving care at one of the participating health facilities. Cases include individuals participating in the COPE intervention; controls are non-COPE participants identified within the same hospital and matched based on similar baseline characteristics. Study findings will improve clinical and patient-decision making and the health of marginalized AI/ANs by informing policies to promote CHR interventions in rural and underserved communities.
Key Dates
- Start date
- Nov 1, 2013
- Status verified
- May 2026
- Primary completion
- Dec 31, 2015
- Completion
- Dec 31, 2015
Study Design
- Enrollment
- 28,813 participants (actual)
Arms
- Arm: COPE participantsIndividuals living with diabetes seen at a study site who were enrolled in the COPE programmatic intervention during the study period. Participation in COPE consists of receiving home visits by a Navajo Community Health Representative (CHR) once or twice a month for a period of at least 12 months. CHRs use structured patient coaching materials to support behavior change. CHRs also check vital signs, monitor blood glucose levels through finger sticks, and facilitate access to appointments and medical refills. CHRs communicate regularly with providers through electronic health record documentation and case management rounds. In-person or telephone communication is be used to address acute issues that may arise.
- Arm: Non-COPE participantsIndividuals living with diabetes seen at a study site, did not participate in the COPE programmatic intervention, and had comparable baseline characteristics.
Primary Outcome Measure
Change in Percentage of Glycated Hemoglobin (HbA1c) [ Time Frame: 24 months ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Chinle Comprehensive Health Care Facility | Chinle | Arizona | 86503 | - |
| Tsehootsooi Medical Center | Fort Defiance | Arizona | 86504 | - |
| Kayenta Health Center | Kayenta | Arizona | 86033 | - |
| Crownpoint Health Center Facility | Crownpoint | New Mexico | 87313 | - |
| Gallup Indian Medical Center | Gallup | New Mexico | 87301 | - |
| Northern Navajo Medical Center | Shiprock | New Mexico | 87420 | - |
Find similar trials in Chinle, AZ
Related Studies
- Early Tracking of Childhood Health Determinants (ETCHED) StudyRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)Recruiting · University of New Mexico · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona